

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | exogenous drug catabolic process (GO:0042738) | 9.43952500 |
| 2 | drug catabolic process (GO:0042737) | 9.08159052 |
| 3 | negative regulation of fibrinolysis (GO:0051918) | 7.99210763 |
| 4 | regulation of fibrinolysis (GO:0051917) | 7.89905214 |
| 5 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.38978989 |
| 6 | L-phenylalanine catabolic process (GO:0006559) | 7.38978989 |
| 7 | epoxygenase P450 pathway (GO:0019373) | 7.22650191 |
| 8 | omega-hydroxylase P450 pathway (GO:0097267) | 7.20007679 |
| 9 | glyoxylate metabolic process (GO:0046487) | 7.08791755 |
| 10 | complement activation, alternative pathway (GO:0006957) | 7.01545016 |
| 11 | regulation of protein activation cascade (GO:2000257) | 6.95297236 |
| 12 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.88424235 |
| 13 | L-phenylalanine metabolic process (GO:0006558) | 6.88424235 |
| 14 | urea metabolic process (GO:0019627) | 6.85880217 |
| 15 | fibrinolysis (GO:0042730) | 6.51206873 |
| 16 | regulation of complement activation (GO:0030449) | 6.48154547 |
| 17 | peptidyl-glutamic acid carboxylation (GO:0017187) | 6.38106529 |
| 18 | protein carboxylation (GO:0018214) | 6.38106529 |
| 19 | nitrogen cycle metabolic process (GO:0071941) | 6.33035727 |
| 20 | cellular glucuronidation (GO:0052695) | 6.11485819 |
| 21 | oxidative demethylation (GO:0070989) | 5.93977084 |
| 22 | bile acid biosynthetic process (GO:0006699) | 5.87097617 |
| 23 | uronic acid metabolic process (GO:0006063) | 5.76098535 |
| 24 | glucuronate metabolic process (GO:0019585) | 5.76098535 |
| 25 | urea cycle (GO:0000050) | 5.72319446 |
| 26 | phenylpropanoid metabolic process (GO:0009698) | 5.67156763 |
| 27 | blood coagulation, intrinsic pathway (GO:0007597) | 5.66981244 |
| 28 | drug metabolic process (GO:0017144) | 5.57425203 |
| 29 | ethanol oxidation (GO:0006069) | 5.47206465 |
| 30 | bile acid metabolic process (GO:0008206) | 5.20260788 |
| 31 | regulation of triglyceride catabolic process (GO:0010896) | 5.16326319 |
| 32 | aromatic amino acid family catabolic process (GO:0009074) | 5.11415368 |
| 33 | negative regulation of cholesterol transport (GO:0032375) | 5.01513811 |
| 34 | negative regulation of sterol transport (GO:0032372) | 5.01513811 |
| 35 | serine family amino acid catabolic process (GO:0009071) | 5.00548427 |
| 36 | alkaloid metabolic process (GO:0009820) | 4.83674278 |
| 37 | negative regulation of blood coagulation (GO:0030195) | 4.69250443 |
| 38 | negative regulation of hemostasis (GO:1900047) | 4.69250443 |
| 39 | bile acid and bile salt transport (GO:0015721) | 4.63597514 |
| 40 | regulation of plasminogen activation (GO:0010755) | 4.55205773 |
| 41 | S-adenosylmethionine metabolic process (GO:0046500) | 4.54754590 |
| 42 | glycine metabolic process (GO:0006544) | 4.49885663 |
| 43 | tyrosine metabolic process (GO:0006570) | 4.47438161 |
| 44 | regulation of humoral immune response (GO:0002920) | 4.44790892 |
| 45 | acylglycerol homeostasis (GO:0055090) | 4.40826586 |
| 46 | triglyceride homeostasis (GO:0070328) | 4.40826586 |
| 47 | protein activation cascade (GO:0072376) | 4.40637437 |
| 48 | amino-acid betaine metabolic process (GO:0006577) | 4.39753658 |
| 49 | ethanol metabolic process (GO:0006067) | 4.35264694 |
| 50 | acute-phase response (GO:0006953) | 4.26451703 |
| 51 | positive regulation of hemostasis (GO:1900048) | 4.24563293 |
| 52 | positive regulation of blood coagulation (GO:0030194) | 4.24563293 |
| 53 | negative regulation of coagulation (GO:0050819) | 4.22272723 |
| 54 | negative regulation of protein activation cascade (GO:2000258) | 4.18896807 |
| 55 | phospholipid efflux (GO:0033700) | 4.18623186 |
| 56 | negative regulation of wound healing (GO:0061045) | 4.15370060 |
| 57 | daunorubicin metabolic process (GO:0044597) | 4.07424467 |
| 58 | polyketide metabolic process (GO:0030638) | 4.07424467 |
| 59 | doxorubicin metabolic process (GO:0044598) | 4.07424467 |
| 60 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.06476185 |
| 61 | complement activation (GO:0006956) | 4.00017302 |
| 62 | positive regulation of coagulation (GO:0050820) | 3.97077790 |
| 63 | complement activation, classical pathway (GO:0006958) | 3.93097548 |
| 64 | hormone catabolic process (GO:0042447) | 3.89345872 |
| 65 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.87528342 |
| 66 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.87528342 |
| 67 | arginine metabolic process (GO:0006525) | 3.84985060 |
| 68 | steroid catabolic process (GO:0006706) | 3.82397321 |
| 69 | cytolysis (GO:0019835) | 3.76038277 |
| 70 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.74558417 |
| 71 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.68625492 |
| 72 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.67565605 |
| 73 | negative regulation of lipase activity (GO:0060192) | 3.66502952 |
| 74 | cholesterol efflux (GO:0033344) | 3.64620734 |
| 75 | macromolecular complex remodeling (GO:0034367) | 3.63959417 |
| 76 | plasma lipoprotein particle remodeling (GO:0034369) | 3.63959417 |
| 77 | protein-lipid complex remodeling (GO:0034368) | 3.63959417 |
| 78 | high-density lipoprotein particle remodeling (GO:0034375) | 3.60924174 |
| 79 | aminoglycoside antibiotic metabolic process (GO:0030647) | 3.59738217 |
| 80 | flavonoid metabolic process (GO:0009812) | 3.59248392 |
| 81 | aromatic amino acid family metabolic process (GO:0009072) | 3.59180206 |
| 82 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.53432992 |
| 83 | serine family amino acid metabolic process (GO:0009069) | 3.52416397 |
| 84 | sodium-independent organic anion transport (GO:0043252) | 3.51159505 |
| 85 | heme transport (GO:0015886) | 3.50896939 |
| 86 | response to mercury ion (GO:0046689) | 3.50649018 |
| 87 | regulation of cholesterol esterification (GO:0010872) | 3.50592683 |
| 88 | negative regulation of complement activation (GO:0045916) | 3.49206764 |
| 89 | imidazole-containing compound metabolic process (GO:0052803) | 3.47932391 |
| 90 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.45734545 |
| 91 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.45734545 |
| 92 | intestinal cholesterol absorption (GO:0030299) | 3.42787117 |
| 93 | opsonization (GO:0008228) | 3.40316415 |
| 94 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.38240961 |
| 95 | xenobiotic metabolic process (GO:0006805) | 3.29197655 |
| 96 | alpha-amino acid catabolic process (GO:1901606) | 3.28281855 |
| 97 | acute inflammatory response (GO:0002526) | 3.27834986 |
| 98 | regulation of lipoprotein particle clearance (GO:0010984) | 3.25879784 |
| 99 | primary alcohol catabolic process (GO:0034310) | 3.25801811 |
| 100 | phospholipid homeostasis (GO:0055091) | 3.25733010 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 8.84078770 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.90913305 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.90644118 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.24344759 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.75520566 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.33234435 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.05100073 |
| 8 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.92013307 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.51926949 |
| 10 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.45944938 |
| 11 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.26061147 |
| 12 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.95713717 |
| 13 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.31663554 |
| 14 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.13710596 |
| 15 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.10161477 |
| 16 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.06404415 |
| 17 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 2.02774327 |
| 18 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.95714992 |
| 19 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.82138283 |
| 20 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.75574911 |
| 21 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.70642163 |
| 22 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.59151497 |
| 23 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.58851242 |
| 24 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.56911678 |
| 25 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.55299829 |
| 26 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.51552808 |
| 27 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.36703589 |
| 28 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.34523829 |
| 29 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.34061971 |
| 30 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.33702400 |
| 31 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.33015012 |
| 32 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.26977445 |
| 33 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.25414483 |
| 34 | MYB_26560356_Chip-Seq_TH2_Human | 1.24158359 |
| 35 | MYB_26560356_Chip-Seq_TH1_Human | 1.22679954 |
| 36 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.18785279 |
| 37 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.17752167 |
| 38 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.17671697 |
| 39 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.15727124 |
| 40 | MAF_26560356_Chip-Seq_TH1_Human | 1.14151810 |
| 41 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.09795253 |
| 42 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.08982571 |
| 43 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.06742688 |
| 44 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.05297793 |
| 45 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.03944025 |
| 46 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.99596054 |
| 47 | UTX_26944678_Chip-Seq_JUKART_Human | 0.96786913 |
| 48 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.96429221 |
| 49 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.95007457 |
| 50 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.94599317 |
| 51 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.93818560 |
| 52 | GATA1_19941826_ChIP-Seq_K562_Human | 0.93075702 |
| 53 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.92314104 |
| 54 | GATA3_26560356_Chip-Seq_TH2_Human | 0.91862021 |
| 55 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.91423645 |
| 56 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.89951342 |
| 57 | SPI1_23127762_ChIP-Seq_K562_Human | 0.89746657 |
| 58 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.89701313 |
| 59 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.87576894 |
| 60 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.86182473 |
| 61 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.85852397 |
| 62 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.84689852 |
| 63 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.84442179 |
| 64 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.84074431 |
| 65 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.83562622 |
| 66 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.82474272 |
| 67 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.82155300 |
| 68 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.81959285 |
| 69 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.81727057 |
| 70 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.81189491 |
| 71 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.80288059 |
| 72 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.78061360 |
| 73 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.77845956 |
| 74 | GATA2_19941826_ChIP-Seq_K562_Human | 0.77764952 |
| 75 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.77397018 |
| 76 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.76514265 |
| 77 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.76336290 |
| 78 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.76158666 |
| 79 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.75500742 |
| 80 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.75479976 |
| 81 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.75184095 |
| 82 | GATA1_22025678_ChIP-Seq_K562_Human | 0.75051203 |
| 83 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.74526141 |
| 84 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.74374255 |
| 85 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.74353821 |
| 86 | MAF_26560356_Chip-Seq_TH2_Human | 0.74274946 |
| 87 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.73670204 |
| 88 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.72929097 |
| 89 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.72503851 |
| 90 | MYC_22102868_ChIP-Seq_BL_Human | 0.72189424 |
| 91 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.72140179 |
| 92 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.71974434 |
| 93 | P300_27268052_Chip-Seq_Bcells_Human | 0.71936052 |
| 94 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.71221077 |
| 95 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.68875804 |
| 96 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.67776612 |
| 97 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.65548579 |
| 98 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.64988891 |
| 99 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.64977111 |
| 100 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.63789669 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.96830275 |
| 2 | MP0005360_urolithiasis | 6.29552976 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.71431266 |
| 4 | MP0005365_abnormal_bile_salt | 5.51518321 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.83893100 |
| 6 | MP0003195_calcinosis | 4.30696060 |
| 7 | MP0003252_abnormal_bile_duct | 3.89045307 |
| 8 | MP0002138_abnormal_hepatobiliary_system | 3.85683801 |
| 9 | MP0003868_abnormal_feces_composition | 3.13201334 |
| 10 | MP0001666_abnormal_nutrient_absorption | 3.02414968 |
| 11 | MP0009697_abnormal_copulation | 2.58037656 |
| 12 | MP0010329_abnormal_lipoprotein_level | 2.42800467 |
| 13 | MP0003191_abnormal_cellular_cholesterol | 2.24625138 |
| 14 | MP0003806_abnormal_nucleotide_metabolis | 2.24005677 |
| 15 | MP0009840_abnormal_foam_cell | 2.18626478 |
| 16 | MP0005332_abnormal_amino_acid | 1.91538708 |
| 17 | MP0005451_abnormal_body_composition | 1.84049912 |
| 18 | MP0000609_abnormal_liver_physiology | 1.82216440 |
| 19 | MP0002118_abnormal_lipid_homeostasis | 1.53429622 |
| 20 | MP0003763_abnormal_thymus_physiology | 1.52942955 |
| 21 | MP0001764_abnormal_homeostasis | 1.46731644 |
| 22 | MP0005464_abnormal_platelet_physiology | 1.38049586 |
| 23 | MP0003656_abnormal_erythrocyte_physiolo | 1.26889316 |
| 24 | MP0001915_intracranial_hemorrhage | 1.25894850 |
| 25 | MP0008260_abnormal_autophagy | 1.25653528 |
| 26 | MP0003436_decreased_susceptibility_to | 1.23415990 |
| 27 | MP0002876_abnormal_thyroid_physiology | 1.21077655 |
| 28 | MP0005319_abnormal_enzyme/_coenzyme | 1.17918168 |
| 29 | MP0005408_hypopigmentation | 1.17392118 |
| 30 | MP0008469_abnormal_protein_level | 1.12493208 |
| 31 | MP0000598_abnormal_liver_morphology | 1.12086424 |
| 32 | MP0000604_amyloidosis | 1.09214444 |
| 33 | MP0001800_abnormal_humoral_immune | 1.07489248 |
| 34 | MP0002132_abnormal_respiratory_system | 1.05208029 |
| 35 | MP0009785_altered_susceptibility_to | 1.03738125 |
| 36 | MP0009763_increased_sensitivity_to | 1.01943977 |
| 37 | MP0003690_abnormal_glial_cell | 0.99595040 |
| 38 | MP0002419_abnormal_innate_immunity | 0.99117505 |
| 39 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.97913642 |
| 40 | MP0005025_abnormal_response_to | 0.96108491 |
| 41 | MP0004883_abnormal_blood_vessel | 0.95626303 |
| 42 | MP0009764_decreased_sensitivity_to | 0.95246509 |
| 43 | MP0009643_abnormal_urine_homeostasis | 0.95243770 |
| 44 | MP0005376_homeostasis/metabolism_phenot | 0.93286123 |
| 45 | MP0001851_eye_inflammation | 0.92583571 |
| 46 | MP0009333_abnormal_splenocyte_physiolog | 0.92209559 |
| 47 | MP0004019_abnormal_vitamin_homeostasis | 0.91345983 |
| 48 | MP0001835_abnormal_antigen_presentation | 0.90470151 |
| 49 | MP0009642_abnormal_blood_homeostasis | 0.82933336 |
| 50 | MP0000685_abnormal_immune_system | 0.81853890 |
| 51 | MP0003300_gastrointestinal_ulcer | 0.80416480 |
| 52 | MP0001845_abnormal_inflammatory_respons | 0.77018918 |
| 53 | MP0004130_abnormal_muscle_cell | 0.75444550 |
| 54 | MP0003303_peritoneal_inflammation | 0.73952002 |
| 55 | MP0002723_abnormal_immune_serum | 0.73879037 |
| 56 | MP0000689_abnormal_spleen_morphology | 0.73588456 |
| 57 | MP0003186_abnormal_redox_activity | 0.73118431 |
| 58 | MP0005000_abnormal_immune_tolerance | 0.72843954 |
| 59 | MP0003724_increased_susceptibility_to | 0.72392018 |
| 60 | MP0005164_abnormal_response_to | 0.71062126 |
| 61 | MP0005397_hematopoietic_system_phenotyp | 0.70715238 |
| 62 | MP0001545_abnormal_hematopoietic_system | 0.70715238 |
| 63 | MP0008874_decreased_physiological_sensi | 0.64817181 |
| 64 | MP0010368_abnormal_lymphatic_system | 0.64265050 |
| 65 | MP0005636_abnormal_mineral_homeostasis | 0.64193623 |
| 66 | MP0006082_CNS_inflammation | 0.63252018 |
| 67 | MP0000858_altered_metastatic_potential | 0.62521475 |
| 68 | MP0005058_abnormal_lysosome_morphology | 0.62427605 |
| 69 | MP0002420_abnormal_adaptive_immunity | 0.60652457 |
| 70 | MP0005395_other_phenotype | 0.60196764 |
| 71 | MP0001819_abnormal_immune_cell | 0.60061231 |
| 72 | MP0003638_abnormal_response/metabolism_ | 0.59904612 |
| 73 | MP0002452_abnormal_antigen_presenting | 0.59899267 |
| 74 | MP0003329_amyloid_beta_deposits | 0.59548416 |
| 75 | MP0002722_abnormal_immune_system | 0.59463398 |
| 76 | MP0005671_abnormal_response_to | 0.59290193 |
| 77 | MP0001661_extended_life_span | 0.58963616 |
| 78 | MP0005266_abnormal_metabolism | 0.58869008 |
| 79 | MP0002971_abnormal_brown_adipose | 0.58393234 |
| 80 | MP0009053_abnormal_anal_canal | 0.57980441 |
| 81 | MP0000249_abnormal_blood_vessel | 0.57855435 |
| 82 | MP0002398_abnormal_bone_marrow | 0.56441311 |
| 83 | MP0000716_abnormal_immune_system | 0.56276554 |
| 84 | MP0010155_abnormal_intestine_physiology | 0.56191856 |
| 85 | MP0005535_abnormal_body_temperature | 0.54469792 |
| 86 | MP0002405_respiratory_system_inflammati | 0.54422555 |
| 87 | MP0002168_other_aberrant_phenotype | 0.54360724 |
| 88 | MP0003866_abnormal_defecation | 0.53130480 |
| 89 | MP0005023_abnormal_wound_healing | 0.51906046 |
| 90 | MP0009765_abnormal_xenobiotic_induced | 0.50278700 |
| 91 | MP0005387_immune_system_phenotype | 0.50254459 |
| 92 | MP0001790_abnormal_immune_system | 0.50254459 |
| 93 | MP0002078_abnormal_glucose_homeostasis | 0.49946858 |
| 94 | MP0002928_abnormal_bile_duct | 0.48321768 |
| 95 | MP0002933_joint_inflammation | 0.48229797 |
| 96 | MP0004947_skin_inflammation | 0.47309630 |
| 97 | MP0005187_abnormal_penis_morphology | 0.46968174 |
| 98 | MP0002332_abnormal_exercise_endurance | 0.46051929 |
| 99 | MP0000465_gastrointestinal_hemorrhage | 0.45940048 |
| 100 | MP0006036_abnormal_mitochondrial_physio | 0.45789986 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 9.35777275 |
| 2 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 9.08650559 |
| 3 | Prolonged partial thromboplastin time (HP:0003645) | 7.81249010 |
| 4 | Hypobetalipoproteinemia (HP:0003563) | 7.76145937 |
| 5 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.24798344 |
| 6 | Complement deficiency (HP:0004431) | 7.23044799 |
| 7 | Joint hemorrhage (HP:0005261) | 5.96712664 |
| 8 | Conjugated hyperbilirubinemia (HP:0002908) | 5.96212012 |
| 9 | Abnormality of complement system (HP:0005339) | 5.88157754 |
| 10 | Systemic lupus erythematosus (HP:0002725) | 5.32486955 |
| 11 | Hyperlipoproteinemia (HP:0010980) | 5.19402551 |
| 12 | Intrahepatic cholestasis (HP:0001406) | 4.68762454 |
| 13 | Abnormality of the common coagulation pathway (HP:0010990) | 4.62721187 |
| 14 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.44949050 |
| 15 | Abnormality of pyrimidine metabolism (HP:0004353) | 4.31002921 |
| 16 | Hypolipoproteinemia (HP:0010981) | 4.25749262 |
| 17 | Xanthomatosis (HP:0000991) | 4.20014014 |
| 18 | Gingival bleeding (HP:0000225) | 4.00835378 |
| 19 | Spontaneous abortion (HP:0005268) | 3.99664952 |
| 20 | Glomerulonephritis (HP:0000099) | 3.90114868 |
| 21 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.70173335 |
| 22 | Fat malabsorption (HP:0002630) | 3.39412317 |
| 23 | Nephritis (HP:0000123) | 3.24840977 |
| 24 | Abnormality of the intrinsic pathway (HP:0010989) | 3.11387998 |
| 25 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.10900008 |
| 26 | Menorrhagia (HP:0000132) | 3.04803725 |
| 27 | Hyperammonemia (HP:0001987) | 2.96129812 |
| 28 | Pulmonary embolism (HP:0002204) | 2.92784088 |
| 29 | Hepatocellular carcinoma (HP:0001402) | 2.89801379 |
| 30 | Hemorrhage of the eye (HP:0011885) | 2.78189576 |
| 31 | Thrombophlebitis (HP:0004418) | 2.77746112 |
| 32 | Abnormality of methionine metabolism (HP:0010901) | 2.73588784 |
| 33 | Hyperglycinemia (HP:0002154) | 2.73351925 |
| 34 | Rickets (HP:0002748) | 2.73237618 |
| 35 | Steatorrhea (HP:0002570) | 2.69134515 |
| 36 | Epistaxis (HP:0000421) | 2.64496400 |
| 37 | Mitral stenosis (HP:0001718) | 2.63355963 |
| 38 | Hypoalphalipoproteinemia (HP:0003233) | 2.62605724 |
| 39 | Hypochromic microcytic anemia (HP:0004840) | 2.60223431 |
| 40 | Purpura (HP:0000979) | 2.60170041 |
| 41 | Generalized aminoaciduria (HP:0002909) | 2.60009943 |
| 42 | Osteomalacia (HP:0002749) | 2.56982325 |
| 43 | Hypercholesterolemia (HP:0003124) | 2.46499242 |
| 44 | Vascular calcification (HP:0004934) | 2.45823988 |
| 45 | Abnormality of nucleobase metabolism (HP:0010932) | 2.45070480 |
| 46 | Joint swelling (HP:0001386) | 2.45062232 |
| 47 | Hyperbilirubinemia (HP:0002904) | 2.31578491 |
| 48 | Recurrent abscess formation (HP:0002722) | 2.30135879 |
| 49 | Eczematoid dermatitis (HP:0000976) | 2.29695798 |
| 50 | Neonatal hypoglycemia (HP:0001998) | 2.26872820 |
| 51 | Increased mean platelet volume (HP:0011877) | 2.24976228 |
| 52 | Poikilocytosis (HP:0004447) | 2.24713730 |
| 53 | Abnormal platelet volume (HP:0011876) | 2.24699547 |
| 54 | T lymphocytopenia (HP:0005403) | 2.21818048 |
| 55 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.21460427 |
| 56 | Abnormality of glycine metabolism (HP:0010895) | 2.21460427 |
| 57 | Increased serum ferritin (HP:0003281) | 2.21040334 |
| 58 | Gangrene (HP:0100758) | 2.19831569 |
| 59 | Myocardial infarction (HP:0001658) | 2.17865984 |
| 60 | Hypochromic anemia (HP:0001931) | 2.17787525 |
| 61 | Abnormality of serum amino acid levels (HP:0003112) | 2.15852815 |
| 62 | Abnormality of iron homeostasis (HP:0011031) | 2.12625235 |
| 63 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.11245873 |
| 64 | Reduced antithrombin III activity (HP:0001976) | 2.10794876 |
| 65 | Cardiovascular calcification (HP:0011915) | 2.09027097 |
| 66 | Hyperphosphaturia (HP:0003109) | 2.06721056 |
| 67 | Arthropathy (HP:0003040) | 2.06383925 |
| 68 | Cholelithiasis (HP:0001081) | 2.06050065 |
| 69 | Hyperglycinuria (HP:0003108) | 2.05012205 |
| 70 | Cholecystitis (HP:0001082) | 2.03031266 |
| 71 | Abnormal gallbladder physiology (HP:0012438) | 2.03031266 |
| 72 | Abnormality of T cell number (HP:0011839) | 2.01609606 |
| 73 | Periodontitis (HP:0000704) | 2.01571457 |
| 74 | Myositis (HP:0100614) | 1.98534584 |
| 75 | Elevated alkaline phosphatase (HP:0003155) | 1.93498662 |
| 76 | Prolonged bleeding time (HP:0003010) | 1.92897586 |
| 77 | Fair hair (HP:0002286) | 1.91871182 |
| 78 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.91159070 |
| 79 | Abnormal gallbladder morphology (HP:0012437) | 1.89401379 |
| 80 | Acanthocytosis (HP:0001927) | 1.87080852 |
| 81 | Metabolic acidosis (HP:0001942) | 1.86538157 |
| 82 | Epidermoid cyst (HP:0200040) | 1.85575604 |
| 83 | Gingivitis (HP:0000230) | 1.83957894 |
| 84 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.81100746 |
| 85 | Stomatitis (HP:0010280) | 1.81042957 |
| 86 | Acute hepatic failure (HP:0006554) | 1.79151260 |
| 87 | Abnormality of urine glucose concentration (HP:0011016) | 1.78306999 |
| 88 | Glycosuria (HP:0003076) | 1.78306999 |
| 89 | Hypophosphatemic rickets (HP:0004912) | 1.78177429 |
| 90 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.77516323 |
| 91 | Optic neuritis (HP:0100653) | 1.77048122 |
| 92 | Retrobulbar optic neuritis (HP:0100654) | 1.77048122 |
| 93 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.76232287 |
| 94 | Gastrointestinal infarctions (HP:0005244) | 1.76179779 |
| 95 | Abnormality of the Achilles tendon (HP:0005109) | 1.75920502 |
| 96 | Meningitis (HP:0001287) | 1.75847127 |
| 97 | Irritability (HP:0000737) | 1.75725225 |
| 98 | Impaired platelet aggregation (HP:0003540) | 1.74535657 |
| 99 | Abnormal platelet function (HP:0011869) | 1.74535657 |
| 100 | Orchitis (HP:0100796) | 1.72550952 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PRPF4B | 4.83544524 |
| 2 | TAOK3 | 4.31525243 |
| 3 | MAP4K1 | 3.31998503 |
| 4 | TAOK2 | 2.74271111 |
| 5 | GRK6 | 2.72829046 |
| 6 | FGFR4 | 2.70633282 |
| 7 | TYK2 | 2.65495623 |
| 8 | PIK3CG | 2.48397885 |
| 9 | TXK | 2.25097115 |
| 10 | MAP2K3 | 2.21503355 |
| 11 | BLK | 2.09362057 |
| 12 | IKBKE | 2.02835111 |
| 13 | JAK1 | 1.95734206 |
| 14 | ERN1 | 1.95682939 |
| 15 | MAP3K3 | 1.93676961 |
| 16 | FGFR3 | 1.85293565 |
| 17 | FES | 1.71102054 |
| 18 | CAMKK2 | 1.65428702 |
| 19 | ZAP70 | 1.63123063 |
| 20 | MAP3K11 | 1.53161156 |
| 21 | JAK3 | 1.51400201 |
| 22 | TBK1 | 1.50751314 |
| 23 | RIPK4 | 1.48455934 |
| 24 | NLK | 1.46432936 |
| 25 | TAOK1 | 1.39461273 |
| 26 | ITK | 1.38158631 |
| 27 | BTK | 1.34606921 |
| 28 | CSK | 1.29113149 |
| 29 | MAP3K1 | 1.29004072 |
| 30 | SYK | 1.25365112 |
| 31 | MAP3K14 | 1.22873629 |
| 32 | MAP3K13 | 1.22054955 |
| 33 | LCK | 1.21411567 |
| 34 | HCK | 1.16709153 |
| 35 | TNK2 | 1.16389732 |
| 36 | TRIB3 | 1.15252810 |
| 37 | JAK2 | 1.14171353 |
| 38 | EPHB1 | 1.07042026 |
| 39 | KIT | 1.04406503 |
| 40 | CSF1R | 1.02975350 |
| 41 | PIM1 | 1.02931310 |
| 42 | MAPK11 | 0.98591532 |
| 43 | RIPK1 | 0.97621681 |
| 44 | PDK1 | 0.96892804 |
| 45 | TRPM7 | 0.94638272 |
| 46 | MAP3K5 | 0.94000048 |
| 47 | STK38 | 0.88449925 |
| 48 | TEC | 0.88434731 |
| 49 | SMG1 | 0.88252239 |
| 50 | PIK3CA | 0.85706646 |
| 51 | SGK2 | 0.84343663 |
| 52 | MAP3K2 | 0.83276846 |
| 53 | LYN | 0.81037316 |
| 54 | CDK4 | 0.80856269 |
| 55 | MARK2 | 0.80186561 |
| 56 | MELK | 0.77823755 |
| 57 | MAP3K10 | 0.77493680 |
| 58 | SGK3 | 0.74598030 |
| 59 | MAPK12 | 0.73596289 |
| 60 | DYRK1A | 0.72171994 |
| 61 | CAMKK1 | 0.72013966 |
| 62 | EPHA3 | 0.71738800 |
| 63 | STK4 | 0.71731620 |
| 64 | TGFBR2 | 0.70207055 |
| 65 | PRKAA2 | 0.69679063 |
| 66 | PDPK1 | 0.68690389 |
| 67 | CDK6 | 0.68227681 |
| 68 | PRKCQ | 0.67775777 |
| 69 | PTK6 | 0.67185449 |
| 70 | SCYL2 | 0.65663280 |
| 71 | GRK5 | 0.65455204 |
| 72 | MAP2K2 | 0.65349071 |
| 73 | STK10 | 0.62375721 |
| 74 | PRKACG | 0.62311830 |
| 75 | STK11 | 0.62226858 |
| 76 | RET | 0.60763658 |
| 77 | ERBB2 | 0.59705783 |
| 78 | CDK12 | 0.59439511 |
| 79 | MAP2K4 | 0.58619201 |
| 80 | BMPR2 | 0.58214987 |
| 81 | FGR | 0.57958702 |
| 82 | MAP3K7 | 0.55563893 |
| 83 | CAMK4 | 0.50470999 |
| 84 | MARK3 | 0.50373320 |
| 85 | IGF1R | 0.50105181 |
| 86 | MAPK7 | 0.49783748 |
| 87 | IKBKB | 0.47635465 |
| 88 | KSR2 | 0.47469420 |
| 89 | IRAK4 | 0.45085735 |
| 90 | HIPK2 | 0.44412130 |
| 91 | FYN | 0.44252507 |
| 92 | SGK494 | 0.43155142 |
| 93 | SGK223 | 0.43155142 |
| 94 | DYRK1B | 0.41908121 |
| 95 | YES1 | 0.41608689 |
| 96 | SGK1 | 0.41552629 |
| 97 | PINK1 | 0.37589403 |
| 98 | PTK2B | 0.36893393 |
| 99 | SIK1 | 0.35927932 |
| 100 | LRRK2 | 0.35337976 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.39198935 |
| 2 | Caffeine metabolism_Homo sapiens_hsa00232 | 4.31411363 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.96107731 |
| 4 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 3.94854628 |
| 5 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.50962036 |
| 6 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 3.42553196 |
| 7 | Retinol metabolism_Homo sapiens_hsa00830 | 3.37024427 |
| 8 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 3.00543747 |
| 9 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.90420190 |
| 10 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.80736170 |
| 11 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 2.74257495 |
| 12 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.71252896 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.70557760 |
| 14 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.41910643 |
| 15 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.22958777 |
| 16 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 2.21424761 |
| 17 | Tyrosine metabolism_Homo sapiens_hsa00350 | 2.15909013 |
| 18 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.08461624 |
| 19 | Bile secretion_Homo sapiens_hsa04976 | 1.92632252 |
| 20 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.83183979 |
| 21 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.82265167 |
| 22 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.74203654 |
| 23 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.71875717 |
| 24 | Histidine metabolism_Homo sapiens_hsa00340 | 1.61874187 |
| 25 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.56141379 |
| 26 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.48180276 |
| 27 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.43113535 |
| 28 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.39790084 |
| 29 | Peroxisome_Homo sapiens_hsa04146 | 1.34782877 |
| 30 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.28311484 |
| 31 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.17983949 |
| 32 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.17929989 |
| 33 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.12350318 |
| 34 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.11715766 |
| 35 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.08435336 |
| 36 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.07953072 |
| 37 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.04234260 |
| 38 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.98979096 |
| 39 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.94953275 |
| 40 | Prion diseases_Homo sapiens_hsa05020 | 0.91460034 |
| 41 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.86902738 |
| 42 | ABC transporters_Homo sapiens_hsa02010 | 0.80172841 |
| 43 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.75255582 |
| 44 | Lysine degradation_Homo sapiens_hsa00310 | 0.73758086 |
| 45 | Carbon metabolism_Homo sapiens_hsa01200 | 0.71224244 |
| 46 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.70584388 |
| 47 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.64473407 |
| 48 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.64267884 |
| 49 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.63780318 |
| 50 | Sulfur relay system_Homo sapiens_hsa04122 | 0.59704541 |
| 51 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.59485453 |
| 52 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.58439041 |
| 53 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.53925304 |
| 54 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.52207242 |
| 55 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.41417661 |
| 56 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.36114737 |
| 57 | Insulin resistance_Homo sapiens_hsa04931 | 0.35793328 |
| 58 | Pertussis_Homo sapiens_hsa05133 | 0.35284708 |
| 59 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.33973125 |
| 60 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.33591200 |
| 61 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.30487411 |
| 62 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.27977743 |
| 63 | Metabolic pathways_Homo sapiens_hsa01100 | 0.27107743 |
| 64 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.24511280 |
| 65 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.20308474 |
| 66 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.17541131 |
| 67 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.16965576 |
| 68 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.16725855 |
| 69 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.16563579 |
| 70 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.14259149 |
| 71 | Other glycan degradation_Homo sapiens_hsa00511 | 0.12703540 |
| 72 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.12444664 |
| 73 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.10611722 |
| 74 | Leishmaniasis_Homo sapiens_hsa05140 | 0.10145959 |
| 75 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.07818828 |
| 76 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.07671788 |
| 77 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.07551821 |
| 78 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.06109796 |
| 79 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.05367678 |
| 80 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.05125616 |
| 81 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.04077902 |
| 82 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.03029557 |
| 83 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.02858274 |
| 84 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | -0.0969863 |
| 85 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.0908712 |
| 86 | Influenza A_Homo sapiens_hsa05164 | -0.0895993 |
| 87 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | -0.0877675 |
| 88 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | -0.0876656 |
| 89 | Serotonergic synapse_Homo sapiens_hsa04726 | -0.0848073 |
| 90 | Amoebiasis_Homo sapiens_hsa05146 | -0.0654864 |
| 91 | Selenocompound metabolism_Homo sapiens_hsa00450 | -0.0612596 |
| 92 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | -0.0510588 |
| 93 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | -0.0406936 |
| 94 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | -0.0329000 |
| 95 | Hepatitis C_Homo sapiens_hsa05160 | -0.0312260 |
| 96 | Measles_Homo sapiens_hsa05162 | -0.0240434 |
| 97 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | -0.0185879 |
| 98 | Platelet activation_Homo sapiens_hsa04611 | -0.0183901 |
| 99 | FoxO signaling pathway_Homo sapiens_hsa04068 | -0.0073584 |
| 100 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.0043831 |

